A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Calusterone
Fenozolone
The risk or severity of Tachycardia can be increased when Nabiximols is combined with Fenozolone.
Calusterone
Mephedrone
The risk or severity of Tachycardia can be increased when Nabiximols is combined with Mephedrone.
Calusterone
Tramazoline
The risk or severity of Tachycardia can be increased when Nabiximols is combined with Tramazoline.
Calusterone
Ritobegron
The risk or severity of Tachycardia can be increased when Nabiximols is combined with Ritobegron.
Calusterone
Racepinephrine
The risk or severity of Tachycardia can be increased when Nabiximols is combined with Racepinephrine.
Calusterone
Iofetamine I-123
The risk or severity of Tachycardia can be increased when Nabiximols is combined with Iofetamine I-123.
Calusterone
Synephrine
The risk or severity of Tachycardia can be increased when Nabiximols is combined with Synephrine.
Calusterone
Etilefrine
The risk or severity of Tachycardia can be increased when Nabiximols is combined with Etilefrine.
Calusterone
Isoxsuprine
The risk or severity of Tachycardia can be increased when Nabiximols is combined with Isoxsuprine.
Calusterone
Tetryzoline
The risk or severity of Tachycardia can be increased when Nabiximols is combined with Tetryzoline.
Calusterone
Chlorphenoxamine
The risk or severity of Tachycardia and drowsiness can be increased when Chlorphenoxamine is combined with Nabiximols.
Calusterone
Timepidium
The risk or severity of Tachycardia and drowsiness can be increased when Timepidium is combined with Nabiximols.
Calusterone
Pipenzolate
The risk or severity of Tachycardia and drowsiness can be increased when Pipenzolate is combined with Nabiximols.
Calusterone
Emetonium iodide
The risk or severity of Tachycardia and drowsiness can be increased when Emetonium iodide is combined with Nabiximols.
Calusterone
Fenpiverinium
The risk or severity of Tachycardia and drowsiness can be increased when Fenpiverinium is combined with Nabiximols.
Calusterone
Camylofin
The risk or severity of Tachycardia and drowsiness can be increased when Camylofin is combined with Nabiximols.
Calusterone
Diphemanil
The risk or severity of Tachycardia and drowsiness can be increased when Diphemanil is combined with Nabiximols.
Calusterone
Penthienate
The risk or severity of Tachycardia and drowsiness can be increased when Penthienate is combined with Nabiximols.
Calusterone
Dihexyverine
The risk or severity of Tachycardia and drowsiness can be increased when Dihexyverine is combined with Nabiximols.
Calusterone
Tiemonium iodide
The risk or severity of Tachycardia and drowsiness can be increased when Tiemonium iodide is combined with Nabiximols.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3